Mechanism of action of novel HCV NS5A inhibitors

Project Information
Description: 

Approximately 200 million people worldwide are infected with the hepatitis C virus (HCV). The vast majority develop chronic infection that is associated with severe liver disease, including hepatic fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Thus, there is a need for the development of treatments that cure infected individuals. Compounds that bind to the non-structural protein 5A (NS5A) have shown antiviral activity in advances clinical trials. In collaboration with Tibotech, we study the mechanism of action of selected molecules with the ultimate goal to provide tools to improve this class drugs.

Project Date: 
01/01/2011 to 09/29/2022
Type of Project: 
Research
Research Area: 
Health Research
Sub-Research Area: 
Virology
Location: 
Belgium
McGill University Project Leader Information
Role: 
Principal Investigator
Non-McGill Partners
Partner: 
Frederik Pauwels

    McGill Global Health Programs Logo